Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology
The objective was to study the effectiveness of the use of hepatoprotector glucuronate at the early stage of intensive therapy of toxic hepatitis of various etiologies.Materials and methods. We studied 120 patients with toxic hepatitis who were treated at the Republican research center for emergency...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2024-10-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/1061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849343519542476800 |
|---|---|
| author | R. N. Akalaev A. M. Khadjibaev A. A. Stopnitskiy D. B. Tulyaganov U. R. Kamilov M. K. Saidova |
| author_facet | R. N. Akalaev A. M. Khadjibaev A. A. Stopnitskiy D. B. Tulyaganov U. R. Kamilov M. K. Saidova |
| author_sort | R. N. Akalaev |
| collection | DOAJ |
| description | The objective was to study the effectiveness of the use of hepatoprotector glucuronate at the early stage of intensive therapy of toxic hepatitis of various etiologies.Materials and methods. We studied 120 patients with toxic hepatitis who were treated at the Republican research center for emergency medicine in 2022–2023. The study was carried out in two groups of patients. Group I – 60 patients admitted in 2023, who, in addition to traditional therapy, received a complex hepatoprotector glucuronate (Jetepar®)*. Group II (comparison group) – 60 patients who applied in 2022 and received only traditional therapy. Biochemical blood parameters were studied upon admission and over time on day 5. The severity of intellectual impairment was assessed using cognitive scales and the Reitan test on days 2 and 5 from the start of treatment.Results. Upon admission, both groups showed signs of toxic liver damage. In dynamics by the 5th day in patients of group I, there was a decrease in ALT by 63.7%, AST by 66.4%, alkaline phosphatase by 54.2% from the initial values, which was 3.9 and 2.6, 2. 1 lower than in the comparison group. The level of free ammonia in patients of group I on the 5th day decreased by 52%, and lactate by 57% from the initial level, almost to the physiological norm, while in the comparison group (II) only by 24.8% and 38.1%, which was 2.2 and 1.5 times worse than in the main group. Screening of the level of intelligence using two cognitive scales and the Reitan test showed that in patients in the comparison group, cognitive function indicators on the 5th day were 1.4, 1.5 and 1.2 times lower than in the main group.Conclusion. The use of the hepatoprotector glucuronate improves liver parameters and cognitive functions in patients with toxic hepatitis. |
| format | Article |
| id | doaj-art-2de0eb99ad5b41c08d2b395264e1565c |
| institution | Kabale University |
| issn | 2078-5658 2541-8653 |
| language | Russian |
| publishDate | 2024-10-01 |
| publisher | New Terra Publishing House |
| record_format | Article |
| series | Вестник анестезиологии и реаниматологии |
| spelling | doaj-art-2de0eb99ad5b41c08d2b395264e1565c2025-08-20T03:42:57ZrusNew Terra Publishing HouseВестник анестезиологии и реаниматологии2078-56582541-86532024-10-01215586510.24884/2078-5658-2024-21-5-58-65711Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiologyR. N. Akalaev0A. M. Khadjibaev1A. A. Stopnitskiy2D. B. Tulyaganov3U. R. Kamilov4M. K. Saidova5Republican research center for emergency medicine; Center for the development of professional qualifications of medical workersCenter for the development of professional qualifications of medical workersRepublican research center for emergency medicine; Center for the development of professional qualifications of medical workersRepublican research center for emergency medicine; Center for the development of professional qualifications of medical workersRepublican research center for emergency medicineRepublican research center for emergency medicineThe objective was to study the effectiveness of the use of hepatoprotector glucuronate at the early stage of intensive therapy of toxic hepatitis of various etiologies.Materials and methods. We studied 120 patients with toxic hepatitis who were treated at the Republican research center for emergency medicine in 2022–2023. The study was carried out in two groups of patients. Group I – 60 patients admitted in 2023, who, in addition to traditional therapy, received a complex hepatoprotector glucuronate (Jetepar®)*. Group II (comparison group) – 60 patients who applied in 2022 and received only traditional therapy. Biochemical blood parameters were studied upon admission and over time on day 5. The severity of intellectual impairment was assessed using cognitive scales and the Reitan test on days 2 and 5 from the start of treatment.Results. Upon admission, both groups showed signs of toxic liver damage. In dynamics by the 5th day in patients of group I, there was a decrease in ALT by 63.7%, AST by 66.4%, alkaline phosphatase by 54.2% from the initial values, which was 3.9 and 2.6, 2. 1 lower than in the comparison group. The level of free ammonia in patients of group I on the 5th day decreased by 52%, and lactate by 57% from the initial level, almost to the physiological norm, while in the comparison group (II) only by 24.8% and 38.1%, which was 2.2 and 1.5 times worse than in the main group. Screening of the level of intelligence using two cognitive scales and the Reitan test showed that in patients in the comparison group, cognitive function indicators on the 5th day were 1.4, 1.5 and 1.2 times lower than in the main group.Conclusion. The use of the hepatoprotector glucuronate improves liver parameters and cognitive functions in patients with toxic hepatitis.https://www.vair-journal.com/jour/article/view/1061acute poisoningsevere burnstoxic hepatitiscomplex hepatoprotectionglucuronatecognitive functions |
| spellingShingle | R. N. Akalaev A. M. Khadjibaev A. A. Stopnitskiy D. B. Tulyaganov U. R. Kamilov M. K. Saidova Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology Вестник анестезиологии и реаниматологии acute poisoning severe burns toxic hepatitis complex hepatoprotection glucuronate cognitive functions |
| title | Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology |
| title_full | Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology |
| title_fullStr | Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology |
| title_full_unstemmed | Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology |
| title_short | Evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology |
| title_sort | evaluation of the efficiency of the hepatoprotector glucuronate in toxic hepatitis of various etiology |
| topic | acute poisoning severe burns toxic hepatitis complex hepatoprotection glucuronate cognitive functions |
| url | https://www.vair-journal.com/jour/article/view/1061 |
| work_keys_str_mv | AT rnakalaev evaluationoftheefficiencyofthehepatoprotectorglucuronateintoxichepatitisofvariousetiology AT amkhadjibaev evaluationoftheefficiencyofthehepatoprotectorglucuronateintoxichepatitisofvariousetiology AT aastopnitskiy evaluationoftheefficiencyofthehepatoprotectorglucuronateintoxichepatitisofvariousetiology AT dbtulyaganov evaluationoftheefficiencyofthehepatoprotectorglucuronateintoxichepatitisofvariousetiology AT urkamilov evaluationoftheefficiencyofthehepatoprotectorglucuronateintoxichepatitisofvariousetiology AT mksaidova evaluationoftheefficiencyofthehepatoprotectorglucuronateintoxichepatitisofvariousetiology |